NIH Doctor Seeks Whistleblower Protection Over AIDS Drug Safety

The expert hired by the National Institutes of Health last year to improve its research practices after problems in an AIDS drug study surfaced is seeking whistleblower protection after disagreements with management have left him on the verge of being fired.

X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
The expert hired by the National Institutes of Health last year to improve its research practices after problems in an AIDS drug study surfaced is seeking whistleblower protection after disagreements with management have left him on the verge of being fired. Dr. Jonathan Fishbein, a 10-year expert on safe drug research practices in the private sector before joining NIH in summer 2003, has met with congressional investigators and provided extensive information about problems in NIH research. NIH officials declined to discuss Fishbein, citing personnel privacy, except to say the move to fire him is based on his performance. Fishbein, who is represented by the National Whistleblower Center, was told earlier this year he is being fired before he completes his two-year employment probation after a series of disputes with NIH managers over safety concerns in various AIDS research projects, according to his lawyer. In one instance, Fishbein refused to discipline an employee for reporting safety concerns to the Food and Drug Administration, and another time he was overruled when he objected to restarting problematic research, documents show. Attorney Stephen M. Kohn, who represents Fishbein, said NIH officials have a built-in conflict because they both fund the research and monitor safety. “He found a system that was broken,” Kohn said. “There’s a tension at NIH. A tension between those doctors who want to push the clinical results, that want to publish, that want to take credit for major breakthroughs, and other doctors and professionals who want to adhere to the quality standards.” Copyright 2004 Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.

Want to continue reading?
Become a Free ALM Digital Reader.

Benefits of a Digital Membership:

  • Free access to 3 articles* every 30 days
  • Access to the entire ALM network of websites
  • Unlimited access to the ALM suite of newsletters
  • Build custom alerts on any search topic of your choosing
  • Search by a wide range of topics

*May exclude premium content
Already have an account?

Trending Stories

 

Featured Product

Global Briefing

A weekly, curated selection of our international content from around the globe, across the business of law, in-house, regulatory, technology and more, with expert insights from our senior editors.

Learn More

More from ALM

 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Privacy Policy

About Us / Contact Us / Site Map / Advertise With Us/ Customer Service / Terms of Service/ FAQ / Privacy Policy

Publications

Law Topics

Rankings

More

Law.com

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.